- Citations, last 5 years
- 199k
- Works, last 5 years
- 15.7k
- h-index
- 1,134
- Scientists listed
- 827
- Grants since 2016
- 1 652
Grants received
2019–2024 · grant · Continuing Grant
CAREER: Experimentally integrated modeling of quality control during eukaryotic mRNA protein synthesis
Arvind Subramaniam · Fred Hutch Cancer Center · funded by National Science Foundation
2019–2024 · research · R01
Discovery and Characterization of Capsid-Targeting Lentiviral Restriction Factors
Molly Ohainle · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Defining the protective efficacy of antibodies against the EBV gH/gL glycoprotein complex
Andrew Mcguire · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2021 · award
Role of cell polarity proteins Llgl1/2 in stem cell homeostasis and cancer
Victor Bii · Fred Hutch Cancer Center · funded by American Cancer Society
2019–2024 · research · R01
Blending deep learning with probabilistic mechanistic models to predict and understand the evolution and function of adaptive immune receptors
Frederick Albert Matsen · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · research · R01
Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
Valeri Vasioukhin · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2021 · grant · DFID-Wellcome Epidemic Preparedness - Cholera Grant
Optimizing vaccine allocation for cholera epidemics
Dr Laura Matrajt · Fred Hutch Cancer Center · funded by Wellcome Trust
2019–2021 · research · R21
A Scalable e-Health Smoking Cessation Intervention for Socioeconomically Disadvantaged Veterans
Jaimee Heffner · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Employing CRISPR inactivation screening and in vivo models towards improving treatments for SCLC
David Macpherson · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Modeling to Minimize Detection Bias in Cancer Risk Prediction Studies
Ruth D Etzioni · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2021 · fellowship · F32
Spatiotemporal mechanisms of in vivo axon initiation and targeting during development
Adam James Isabella · Fred Hutch Cancer Center · funded by National Institutes of Health
2019 · fellowship · F32
Autocrine and paracrine mechanisms of HA-driven metastasis in pancreas cancer
Heather Jeanne Wright · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Characterizing determinants of primary KSHV infection among children and adolescents in Uganda
Jackson Orem · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2021 · fellowship · F32
Mechanisms of massive genome reactivation during quiescence exit
Christine E Cucinotta · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2021 · fellowship · F99
Profiling and leveraging bystander T cells within the tumor microenvironment
Nicholas Joseph Maurice · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · research · R01
Discovery and Characterization of Capsid-Targeting Lentiviral Restriction Factors
Molly Ohainle · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Defining the protective efficacy of antibodies against the EBV gH/gL glycoprotein complex
Andrew Mcguire · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2021 · research · R21
Germline genetic factors regulating immune response to tumors and their contribution to colorectal cancer risk and prognosis
Jeroen R Huyghe · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · research · R01
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
Brian Till · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · fellowship · F32
Investigating the Role of DNA Repair Mutations in Prostate Cancer Initiation, Progression, and Susceptibility to Targeted Therapies
Sander Barkley Frank · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Biologic correlatives of chronic GVHD onset
Stephanie J Lee · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · program · P50
Fred Hutchinson Cancer Research Center Lung SPORE
A Mcgarry Houghton · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Characterizing determinants of primary KSHV infection among children and adolescents in Uganda
Jackson Orem · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · research · R01
Engineering knotted peptide therapeutics for pediatric brain tumor patients
James M Olson · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · cooperative agreement · UH3
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance
Daniel W. Lin · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
Brian Till · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2026 · research · Global Health
Fred Hutchinson Cancer Center - to discover circulating markers to determine the size of the HIV reservoir in the body, to clinically test interventions that might reduce the size...
Fred Hutch Cancer Center · funded by Bill and Melinda Gates Foundation
2019–2022 · research · R01
Targeting macrophages in metastatic cancer
Anthony Rongvaux · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Targeting macrophages in metastatic cancer
Anthony Rongvaux · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · research · R01
Modeling to Minimize Detection Bias in Cancer Risk Prediction Studies
Ruth D Etzioni · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · research · R01
Defining the protective efficacy of antibodies against the EBV gH/gL glycoprotein complex
Andrew Mcguire · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2021 · research · R21
Evaluating Novel Targeted Therapies in Cholangiocarcinoma Using Tumor Slice Cultures
Sita Kugel · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Tumor-specific autoantibodies for SCLC early detection
A Mcgarry Houghton · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · career development · K08
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
Rachel B. Issaka · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · research · R21
A Scalable e-Health Smoking Cessation Intervention for Socioeconomically Disadvantaged Veterans
Jaimee Heffner · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · research · R00
Defining novel genetic dependencies in spliceosome mutant leukemia
Stanley Chun-Wei Lee · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · research · R00
Defining novel genetic dependencies in spliceosome mutant leukemia
Stanley Chun-Wei Lee · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Employing CRISPR inactivation screening and in vivo models towards improving treatments for SCLC
David Macpherson · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2022 · cooperative agreement · U01
Optimizing myeloma-specific immunity after autologous stem cell transplantation
Geoffrey Roger Hill · Fred Hutch Cancer Center · funded by National Institutes of Health
2019–2023 · research · R01
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
Bruce R Blazar · Fred Hutch Cancer Center · funded by National Institutes of Health